Pseudovirus News and Research

RSS
SARS-CoV-2 does not infect the entire body in the same way, finds study

SARS-CoV-2 does not infect the entire body in the same way, finds study

COVID-19 vaccine candidate shows potential against SARS-CoV-2 and potential future zoonotic coronaviruses

COVID-19 vaccine candidate shows potential against SARS-CoV-2 and potential future zoonotic coronaviruses

SARS-CoV-2 nucleoprotein increases infectivity of spike-based pseudoviruses

SARS-CoV-2 nucleoprotein increases infectivity of spike-based pseudoviruses

Bats and pangolins in Southeast Asia harbor SARS-CoV-2-related coronaviruses, study finds

Bats and pangolins in Southeast Asia harbor SARS-CoV-2-related coronaviruses, study finds

British and South African SARS-CoV-2 variants show some resistance to neutralizing antibodies

British and South African SARS-CoV-2 variants show some resistance to neutralizing antibodies

Nanoparticle COVID-19 vaccine stimulates robust and long lasting immunity in primates

Nanoparticle COVID-19 vaccine stimulates robust and long lasting immunity in primates

Both mRNA vaccines protect against emerging variants of SARS-CoV-2

Both mRNA vaccines protect against emerging variants of SARS-CoV-2

Inhibition of protein glycosylation successfully prevents SARS-CoV-2 infection in vitro

Inhibition of protein glycosylation successfully prevents SARS-CoV-2 infection in vitro

Researchers engineer "Nanotraps" that block SARS-CoV-2 infection

Researchers engineer "Nanotraps" that block SARS-CoV-2 infection

Study shows BioNTech-Pfizer COVID-19 vaccine's ability to neutralize UK viral variant

Study shows BioNTech-Pfizer COVID-19 vaccine's ability to neutralize UK viral variant

Variants emerging during COVID-19 pandemic resist antibody neutralization

Variants emerging during COVID-19 pandemic resist antibody neutralization

Moderna vaccine fully neutralizes new SARS-CoV-2 variants, study shows

Moderna vaccine fully neutralizes new SARS-CoV-2 variants, study shows

New SARS-CoV-2 variants resistant to convalescent sera and and monoclonal antibodies

New SARS-CoV-2 variants resistant to convalescent sera and and monoclonal antibodies

Promising nanobodies against COVID-19 produced by llamas

Promising nanobodies against COVID-19 produced by llamas

Transcriptional regulator BRD2 as a potential therapeutic target for COVID-19

Transcriptional regulator BRD2 as a potential therapeutic target for COVID-19

Novel neutralizing antibodies targeting SARS-CoV-2 N-terminal domain discovered

Novel neutralizing antibodies targeting SARS-CoV-2 N-terminal domain discovered

Pfizer-BioNTech vaccine shows reduced neutralization potential against SARS-CoV-2 B.1.1.7 spike variant

Pfizer-BioNTech vaccine shows reduced neutralization potential against SARS-CoV-2 B.1.1.7 spike variant

A high-temperature tolerant SARS-CoV-2 derived immunogen as a potential vaccine candidate

A high-temperature tolerant SARS-CoV-2 derived immunogen as a potential vaccine candidate

Could intranasal SARS-CoV-2 vaccines be a practical alternative to intramuscular shots?

Could intranasal SARS-CoV-2 vaccines be a practical alternative to intramuscular shots?

Discovery of SARS-CoV-2 neutralizing antibodies from a naïve human Ab library

Discovery of SARS-CoV-2 neutralizing antibodies from a naïve human Ab library